M&A Deal Summary |
|
---|---|
Date | 2011-05-19 |
Target | Nycomed Pharma AG |
Sector | Life Science |
Buyer(s) | Takeda |
Sellers(s) |
Avista Healthcare Partners
Nordic Capital HarbourVest Partners Stockwell Capital aPriori Capital Partners |
Deal Type | Add-on Acquisition |
Deal Value | 9.6B EUR |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1781 |
Sector | Life Science |
Employees | 47,347 |
Revenue | 4.03T JPY (2023) |
Takeda is a global biopharmaceutical organization committed to improving the health and well-being of people worldwide. Takeda is dedicated to addressing unmet medical needs through the development of innovative and transformative therapies. The Company's diverse portfolio encompasses a wide range of therapeutic areas, including oncology, gastroenterology, rare diseases, neuroscience, and vaccines. Takeda was originally established in 1781 and is based in Tokyo, Japan.
DEAL STATS | # |
---|---|
Overall | 4 of 18 |
Sector (Life Science) | 4 of 17 |
Type (Add-on Acquisition) | 4 of 15 |
Country (Switzerland) | 1 of 1 |
Year (2011) | 1 of 2 |
Size (of disclosed) | 2 of 9 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2008-05-13 |
Millennium Pharmaceuticals
Cambridge, Massachusetts, United States Millennium Pharmaceuticals, Inc. is a biopharmaceutical company. Millennium research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium is developing an exciting pipeline of innovative product candidates. |
Buy | $8.8B |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2011-12-21 |
Intellikine
La Jolla, California, United States Intellikine, Inc. is a private company focused on the development of innovative, small molecule drugs targeting the PI3K/mTOR pathway for the treatment of cancer and other serious diseases. |
Buy | $190M |
Category | Private Equity Firm |
---|---|
Founded | 2005 |
PE ASSETS | 8.0B USD |
Size | Mega |
Type | Sector Focused |
Avista Capital Partners is a private investment firm formed by a group of professionals with roots from DLJ Merchant Banking Partners. Avista makes controlling and minority investments in US based energy, healthcare, and media companies with revenues greater than $25 million. Typical transactions include leverage buyouts, build-ups, and growth capital financings. Avista Capital was formed in 2005 and is based in New York City with an additional office in Houston, Texas.
DEAL STATS | # |
---|---|
Overall | 7 of 30 |
Sector (Life Science) | 1 of 7 |
Type (Add-on Acquisition) | 3 of 15 |
Country (Switzerland) | 1 of 1 |
Year (2011) | 1 of 1 |
Size (of disclosed) | 1 of 11 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2011-05-12 |
Appalachian Midstream Partners
Columbus, Ohio, United States Appalachian Midstream Partners’ primary asset is a 23 mile 24” natural gas fuel line which connects multiple interstate pipelines to an industrial development outside Toledo, Ohio. AMP also owns and operates a 56-mile pipeline and right-of-way that provides access to the Leidy Storage field and multiple major interstate pipelines in north-central Pennsylvania located in the Marcellus Shale fairway. Appalachian Midstream Partners is based in Columbus, Ohio. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2011-06-13 |
Sidewinder Drilling
Houston, Texas, United States Sidewinder is a land-based drilling contractor that utilizes a technologically advanced fleet of highly mobile, operationally flexible, ultra-efficient land drilling rigs to service exploration and production companies. Sidewinder Drilling was founded in 2011 and is based in Houston, Texas. |
Buy | - |
Category | Private Equity Firm |
---|---|
Founded | 1989 |
PE ASSETS | 31.0B EUR |
Size | Mega |
Type | Sector Agnostic |
Nordic Capital is a private equity investment firm that targets mid to large-sized company investments located in Northern Europe as well as the US. Nordic seeks investments across a wide range of industries and prefers situations where there are 'opportunities for new industrial combinations, strategic repositioning, international expansion and operational improvements'. Nordic Capital was formed in 1989 and is based in Stockholm, Sweden.
DEAL STATS | # |
---|---|
Overall | 31 of 79 |
Sector (Life Science) | 3 of 6 |
Type (Add-on Acquisition) | 13 of 24 |
Country (Switzerland) | 3 of 4 |
Year (2011) | 2 of 5 |
Size (of disclosed) | 1 of 17 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2011-04-28 |
Falck
Copenhagen, Denmark Falck is a provider of rescue and safety courses. Falck’s activities are directed at preventing accidents and disease; providing assistance in situations of emergency, accidents and need; and helping people move on with their lives after illness or accidents. Falck was founded in 1906 and is based in Copenhagen, Denmark. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2011-05-20 |
Bulten
Gothenburg, Sweden Bulten is a provider of fasteners to the European automotive industry. The company’s product range includes everything from customer-specific standard products to specialist, customized fasteners. The company also provides technical development, line-feeding, logistics, material, and production expertise. Bulten was founded in 1873 and is based in Gothenburg, Sweden. |
Sell | - |
Category | Private Equity Firm |
---|---|
Founded | 1978 |
PE ASSETS | 86.0B USD |
Size | Mega |
Type | Sector Agnostic |
HarbourVest Partners, LLC is an investment firm that makes investments in new private equity partnerships, acquires secondary interests, and makes direct investments in operating companies. HarbourVest's largest investment area is investments in private equity funds, comprising of approximately 2/3 of HarbourVest's assets. HarbourVest's direct investment group looks for investments in growth oriented businesses at a variety of stages. The Group generally targets co-investments of $5 to $100 million, growth capital financings of $5 to $40 million, or mezzanine commitments of $5 to $20 million. Sectors of interest include software, hardware, data communications, telecommunications, and financial services. HarbourVest was formed in 1997 to assume the business of Hancock Venture Partners which was formed in 1982. HarbourVest Partners is based in Boston, Massachusetts, with additional offices in London, Tokyo, and Hong Kong.
DEAL STATS | # |
---|---|
Overall | 24 of 133 |
Sector (Life Science) | 2 of 5 |
Type (Add-on Acquisition) | 7 of 57 |
Country (Switzerland) | 1 of 2 |
Year (2011) | 3 of 8 |
Size (of disclosed) | 2 of 39 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2011-05-19 |
Roompot
Goes, Netherlands Roompot is a holiday park operator active in the exploitation of holiday parks, tour operating services for third party holiday parks, and the development of holiday parks. Roompot was founded in 1965 and is based in Goes, Netherlands. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2011-05-26 |
FreeScale Semiconductor
Austin, Texas, United States Freescale Semiconductor, Inc. is a designer and manufacturer of embedded semiconductors for the automotive, consumer, industrial, networking and wireless markets. FreeScale designs, researches and development, manufacturing or sales operations in more than 30 countries. |
Sell | - |
Category | Private Equity Firm |
---|---|
Founded | 2002 |
PE ASSETS | 750M USD |
Size | Middle-Market |
Type | Sector Agnostic |
Stockwell Capital is a co-investment firm, focused on making minority investments alongside private equity sponsors. Stockwell is a generalist investor, with no sector preferences and looks to commit $3 to $10 million per investment. The Firm will consider opportunities throughout the US and Europe and prefers late-stage or growth equity situations. Stockwell Capital was formed in 2002 and is based in Chicago.
DEAL STATS | # |
---|---|
Overall | 10 of 41 |
Sector (Life Science) | 1 of 1 |
Type (Add-on Acquisition) | 3 of 12 |
Country (Switzerland) | 1 of 1 |
Year (2011) | 3 of 4 |
Size (of disclosed) | 1 of 17 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2011-02-04 |
Neurotherm
Wilmington, Massachusetts, United States NeuroTherm is a developer, manufacturer and provider of medical products used in interventional pain management. NeuroTherm’s products include radiofrequency (“RF”) generators and related consumable products as well as epidural catheters, discography devices, intradiscal therapies, pharmaceutical compounding and procedure tables. Neurotherm was formed in 2005 and is based in Wilmington, Massachusetts. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2011-10-24 |
HIT Entertainment
London, United Kingdom HIT Entertainment is one of the world's leading independent children's entertainment producers and rights-owners. HIT's portfolio includes properties, such as Thomas & Friends™, Barney™, Bob the Builder™, Fireman Sam™, Angelina Ballerina™, Mike the Knight™, Pingu™ and Rainbow Magic™. Launched in 1989, HIT's lines of business span television and video production, content distribution, publishing, consumer products licensing and live events and has operations in the UK, US, Canada, Hong Kong and Japan. |
Sell | $680M |
Category | Private Equity Firm |
---|---|
Founded | 1985 |
PE ASSETS | 2.0B USD |
Size | Large |
Type | Sector Agnostic |
aPriori Capital Partners (formerly DLJ Merchant Banking Partners) is a middle-market private equity firm focused on middle-market buyouts in the US and Europe. Sectors of interest include healthcare, retail, consumer, energy, business services, and industrial. aPriori was originally established in 1985 and has offices in New York and Los Angeles.
DEAL STATS | # |
---|---|
Overall | 32 of 51 |
Sector (Life Science) | 7 of 9 |
Type (Add-on Acquisition) | 14 of 22 |
Country (Switzerland) | 3 of 3 |
Year (2011) | 2 of 4 |
Size (of disclosed) | 1 of 21 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2011-02-17 |
NextPharma Technologies
London, United Kingdom NextPharma Technologies is a pharmaceutical contract development and manufacturing organization serving worldwide markets. NextPharma provides a full range of pharmaceutical services across the entire supply chain, including pharmaceutical development, clinical trial services, analytical services, commercial manufacturing and packaging, generic dossiers, and licensing. NextPharma Technologies was founded in 2000 and is based in London, United Kingdom. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2011-06-01 |
Enduring Resources II
Denver, Colorado, United States Enduring Resources II LLC is focused on pursuing a diverse portfolio of acquisition and exploitation opportunities in central onshore U.S. basins. Enduring Resources II was founded in 2011 and is based in Denver, Colorado. |
Buy | - |